To study the positive effect of Sidenafil on quality of life and exercise capacity in heart disease patients
Not Applicable
Completed
- Conditions
- Health Condition 1: null- patients suffering from chronic heart disease
- Registration Number
- CTRI/2018/01/011335
- Lead Sponsor
- ONE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 38
Inclusion Criteria
1.Age >18yrs
2.Patients with BIVENTRICULAR DYSFUCTION i.e ( LVSF and RVSF <40%) and secondary pulmonary hypertension
3.Patients on optimal maximal medical therapy
4.Reversible causes of cardiomyopathy ruled out
5.Non revascularizable CAD( on basis of viability testing or coronary vessels not suitable for PTCA or grafting)
Exclusion Criteria
Patients with other associated co morbidities which affect the pulmonary artery pressure and RVEF like COPD, connective tissue disorder, CTEP, valvular heart disease, OSA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method